We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.09%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$235M
AUM Growth
+$87.8M
(+60%)
Cap. Flow
+$81.1M
Cap. Flow
% of AUM
34.53%
Top 10 Holdings %
Top 10 Hldgs %
9.76%
Holding
779
New
236
Increased
178
Reduced
104
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.52M |
| 2 |
Keurig Dr Pepper
KDP
|
+$2.4M |
| 3 |
Wells Fargo
WFC
|
+$2.19M |
| 4 |
AET
Aetna Inc
AET
|
+$2.17M |
| 5 |
PNC Financial Services
PNC
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$1.39M |
| 2 |
Eaton
ETN
|
+$1.38M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$1.35M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$1.32M |
| 5 |
DaVita
DVA
|
+$1.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.9% |
| 2 | Consumer Discretionary | 14.51% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 13.03% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Fidelity National Information Services
FIS
$24.2B
| $38K | 0.02% |
600
-3,000
| -83% | -$180K |
|
452
Thor Industries
THO
$4.06B
| $38K | 0.02% |
+600
| New | +$32.9K |
|
453
East-West Bancorp
EWBC
$17.8B
| $36K | 0.02% |
+1,105
| New | +$36.1K |
|
454
Jacobs Solutions
J
$16B
| $36K | 0.02% |
991
-9,551
| -91% | -$312K |
|
455
Whirlpool
WHR
$2.49B
| $36K | 0.02% |
+200
| New | +$29.8K |
|
456
BOK Financial
BOKF
$8.58B
| $33K | 0.01% |
+600
| New | +$31.3K |
|
457
Parker-Hannifin
PH
$120B
| $33K | 0.01% |
+300
| New | +$30.1K |
|
458
XPO
XPO
$23.4B
| $33K | 0.01% |
+3,149
| New | +$27.5K |
|
|
NFX
459
DELISTED
Newfield Exploration
NFX
| $33K | 0.01% |
+989
| New | +$27.9K |
|
460
US Bancorp
USB
$97.9B
| $32K | 0.01% |
800
-11,100
| -93% | -$443K |
|
461
Coty
COTY
$2.4B
| $31K | 0.01% |
1,105
+1,103
| +55,150% | +$28.9K |
|
462
Alkermes
ALKS
$8.11B
| $30K | 0.01% |
881
+800
| +988% | +$31.6K |
|
463
Broadridge
BR
$18.4B
| $30K | 0.01% |
500
-15,000
| -97% | -$818K |
|
464
Myriad Genetics
MYGN
$476M
| $30K | 0.01% |
800
-800
| -50% | -$30.1K |
|
|
WFM
465
DELISTED
Whole Foods Market Inc
WFM
| $29K | 0.01% |
+921
| New | +$28.8K |
|
466
Deutsche Bank
DB
$66.6B
| $27K | 0.01% |
+1,793
| New | +$30K |
|
467
Toro Company
TTC
$8.79B
| $26K | 0.01% |
+600
| New | +$23.1K |
|
|
CS
468
DELISTED
Credit Suisse Group
CS
| $25K | 0.01% |
+1,800
| New | +$28.6K |
|
|
HZNP
469
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $25K | 0.01% |
+1,494
| New | +$26.1K |
|
470
Werner Enterprises
WERN
$2.2B
| $24K | 0.01% |
+900
| New | +$22.8K |
|
|
POT
471
DELISTED
Potash Corp Of Saskatchewan
POT
| $24K | 0.01% |
+1,429
| New | +$24K |
|
472
DNOW Inc
DNOW
$2.44B
| $23K | 0.01% |
+1,300
| New | +$20K |
|
473
Lincoln Electric
LECO
$14.1B
| $23K | 0.01% |
400
-1,100
| -73% | -$59.9K |
|
|
CEO
474
DELISTED
CNOOC Limited
CEO
| $23K | 0.01% |
+200
| New | +$20.9K |
|
475
CDW
CDW
$18.9B
| $21K | 0.01% |
500
-6,200
| -93% | -$242K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2016 Portfolio in Review
As of Q1 2016, Seven Eight Capital held 779 positions worth $235M, up 60% from $147M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Seven Eight Capital deployed $81.1M of net new capital in Q1 2016, opening 236 new positions and adding to 178 existing holdings. Its largest new stake was Allergan plc: 8,800 shares worth $2.36M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $884K trimmed.
- Seven Eight Capital's largest Q1 2016 buy was Allergan plc: 8,800 shares worth $2.36M.
- Seven Eight Capital added most to Wells Fargo in Q1 2016, an estimated $2.19M increase.
- Seven Eight Capital's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $884K.
- Seven Eight Capital fully exited Halliburton in Q1 2016, selling an estimated $1.39M.
- Seven Eight Capital's ten largest holdings make up 9.8% of its $235M portfolio in Q1 2016.
- Seven Eight Capital opened 236 new positions and closed 257 in Q1 2016.
- Seven Eight Capital's portfolio value rose 60% quarter-over-quarter to $235M.
Based on Seven Eight Capital's 13F filing for Q1 2016, filed 16 May 2016.